|1.23 -0.1 (-7.52%)||12-06 16:00|
|Targets||6-month :||2.93||1-year :||4.02|
|Resists||First :||2.51||Second :||3.45|
|Supports||First :||1||Second :||0.83|
|MAs||MA(5) :||1.24||MA(20) :||1.48|
|MA(100) :||2.11||MA(250) :||1.7|
|MACD||MACD :||-0.3||Signal :||-0.4|
|%K %D||K(14,3) :||33.9||D(3) :||27.4|
|52-week||High :||5.38||Low :||0.68|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ NVOS ] has closed above bottom band by 21.2%. Bollinger Bands are 63.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||1.35 - 1.36||1.36 - 1.37|
|Low:||1.16 - 1.17||1.17 - 1.18|
|Close:||1.22 - 1.23||1.23 - 1.24|
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Medical Care Facilities
|Shares Out||17 (M)|
|Shares Float||13 (M)|
|Held by Insiders||0 (%)|
|Held by Institutions||0 (%)|
|Shares Short||1,270 (K)|
|Shares Short P.Month||1,120 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||1.83|
|Profit Margin||0 %|
|Operating Margin||-43.5 %|
|Return on Assets (ttm)||-12.1 %|
|Return on Equity (ttm)||-92.5 %|
|Qtrly Rev. Growth||-76.2 %|
|Gross Profit (p.s.)||0|
|Sales Per Share||0.06|
|Qtrly Earnings Growth||0 %|
|Operating Cash Flow||-1 (M)|
|Levered Free Cash Flow||2 (M)|
|Price to Book value||0.67|
|Price to Sales||18.46|
|Price to Cash Flow||-15.44|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|